Trial Summary
What is the purpose of this trial?
We propose a clinical study of medial forebrain bundle DBS as a treatment in 20 patients with treatment refractory depression (TRD). Data from the University of Bonn indicates that surgical lesions of the medical forebrain bundle can produce therapeutic benefits in patients with depressive disorders, and suggest that DBS at the same site may also reduce symptomatology in these TRD patients (Schaepfer, 2013). Depression affects up to 10% of the US population and of those at least 10-15% do not benefit from therapies hence why we must explore new treatments. The Percept™ PC system manufactured by Medtronic Neurological will be used in this study. Study subjects will be between the ages of 22 and 70 years of age and suffer from TRD, have failed multiple treatment regimens, including ECT, and remain symptomatic. Those identified as TRD patients will then be enrolled in a clinical pilot study investigating DBS, targeting the MFB.
Research Team
Joao Quevedo, MD, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Giovana Zunta Soares, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Jair C Soares, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for adults aged 22-70 with severe, treatment-resistant depression (TRD) who have tried multiple medications, psychotherapy, and possibly ECT without success. Participants must be in generally good health and not currently abusing substances. Pregnant women or those at risk of pregnancy without effective contraception are excluded.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Deep Brain Stimulation Model 3387 Model 3389 (Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Dr. LaTanya Love
The University of Texas Health Science Center, Houston
Interim President
MD from UT Medical Branch in Galveston
Dr. Jagat Narula
The University of Texas Health Science Center, Houston
Chief Academic Officer since 2023
MD, PhD
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc